MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2025.1695468

Медицинская библиотека · Frontiers in oncology · 2025

Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversight.

Dinc Udo S, Sarkar Jibak, Schubert Philipp, Semrau Sabine, Weissmann Thomas, Karius Andre, Brand Johann, Axer Bernd-Niklas, Gomaa Ahmed, Stephan Pluvio, Sheth Ishita, Beirami Sogand, Schwarz Annette, Gaipl Udo, Frey Benjamin, Bert Christoph, Corradini Stefanie, Fietkau Rainer, Putz Florian

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Large language models (LLM) have shown great potential in clinical decision support and medical education. GPT-5 is a novel LLM system that has been specifically marketed towards oncology use. This study comprehensively benchmarks GPT-5 for the field of radiation oncology.

METHODS

Performance was assessed using two complementary benchmarks: (i) the American College of Radiology Radiation Oncology In-Training Examination (TXIT, 2021), comprising 300 multiple-choice items, and (ii) a curated set of 60 authentic radiation oncologic vignettes representing diverse disease sites and treatment indications. For the vignette evaluation, GPT-5 was instructed to generate structured therapeutic plans and concise two-line summaries. Four board-certified radiation oncologists independently rated outputs for correctness, comprehensiveness, and hallucinations. Inter-rater reliability was quantified using Fleiss' κ. GPT-5-14 results were compared to published GPT-3.5 and GPT-4 baselines.

RESULTS

On the TXIT benchmark, GPT-5 achieved a mean accuracy of 92.8%, outperforming GPT-4 (78.8%) and GPT-3.5 (62.1%). Domain-specific gains were most pronounced in dose specification and diagnosis. In the vignette evaluation, GPT-5's treatment recommendations were rated highly for correctness (mean 3.24/4, 95% CI: 3.11-3.38) and comprehensiveness (3.59/4, 95% CI: 3.49-3.69). Hallucinations were rare, flagged in 10.0% of all individual reviewer assessments (24 of 240), and no patient case reached majority consensus for their presence. Inter-rater agreement was low (Fleiss' κ 0.083 for correctness), reflecting inherent variability in clinical judgment. Errors clustered in complex scenarios requiring precise trial knowledge or detailed clinical adaptation.

DISCUSSION: GPT-5 clearly outperformed prior model variants on the radiation oncology multiple-choice benchmark. Although GPT-5 exhibited favorable performance in generating real-world radiation oncology treatment recommendations, correctness ratings indicate room for further improvement. While hallucinations were infrequent, the presence of substantive errors underscores that GPT-5-generated recommendations require rigorous expert oversight before clinical implementation. In addition, considerable inter-rater variability highlights the challenge of achieving consistent expert evaluation.

Для цитирования: Dinc Udo S, Sarkar Jibak, Schubert Philipp, Semrau Sabine, Weissmann Thomas, Karius Andre, Brand Johann, Axer Bernd-Niklas, Gomaa Ahmed, Stephan Pluvio, Sheth Ishita, Beirami Sogand, Schwarz Annette, Gaipl Udo, Frey Benjamin, Bert Christoph, Corradini Stefanie, Fietkau Rainer, Putz Florian. Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversight.. Frontiers in oncology. 2025. DOI: 10.3389/fonc.2025.1695468.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.